stockrowOrganigram Global Inc. (OGI) vs Organogenesis (ORGO)
- Organigram Global Inc. OGI 0.88 −5.38%
- Organogenesis ORGO 0.89 +5.95%
Organigram Global Inc. and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Organigram Global Inc. is the larger, with a market value of $131.1M against $108.1M — 1.2× the size. Organogenesis has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.0×. Organigram Global Inc. grew revenue faster over the last twelve months: 39.5% against −24.3%. Organigram Global Inc. has the higher net margin (28.4% vs −43.5%) and the higher return on invested capital (−1.53% vs −52.2%). Across the 19 metrics below, Organigram Global Inc. leads on 11 and Organogenesis on 8.
Valuation
Profitability
| Metric | OGI | ORGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 36.47% | 65.56% | 53.51% |
| Operating margin | (3.91%) | (24.45%) | 0.00% |
| Net margin | 28.44% | (43.50%) | (2.45%) |
| Free cash flow margin | (9.46%) | 1.01% | 0.00% |
| Return on equity | 20.20% | (81.71%) | (0.80%) |
| Return on assets | 12.70% | (34.86%) | (1.67%) |
| Return on invested capital | (1.53%) | (52.15%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack